+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07819656

Observational Study Evaluating a Dynamic Risk Model for Severe Treatment-Related Myelosuppression in Adults with Nasopharyngeal Carcinoma

Led by Nanfang Hospital, Southern Medical University · Updated on 2026-09-15

1782

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a multicenter, prospective observational study to evaluate a dynamic risk prediction model for severe treatment-related myelosuppression in patients with nasopharyngeal carcinoma receiving systemic therapy. This model estimates the risk of serious anemia, thrombocytopenia, and leukopenia or neutropenia during treatment cycles. Adult patients with confirmed nasopharyngeal carcinoma receiving systemic anticancer therapy as part of routine clinical care will be enrolled consecutively. Clinical and laboratory data will be collected before each treatment cycle to update risk predictions. Treatment and supportive care will follow standard clinical practice, and the models predictions will be used only for research without influencing patient care. Participants will be followed through all systemic treatment cycles and for 28 days after the last treatment. Researchers will collect routine clinical and lab data during this period to evaluate the models predictive accuracy for grade 3 or higher myelosuppression. This observational approach allows monitoring without altering treatment, with the study expected to complete by June 2028.

CONDITIONS

Brief Title

Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma

Research Team

J

Jian Guan

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here